Cipla gains post final USFDA approval for Pregabalin capsule Cipla gains post final USFDA approval for Pregabalin capsule DSIJ Intelligence / Monday, July 22, 2019 0 2507 Article rating: 3.7 InvaGen Pharmaceuticals Inc, Cipla’s wholly-owned subsidiary has received final approval for its Abbreviated New Drug Application (ANDA) for Pregabalin Capsules. Read more
Lauras Labs launches pregabalin capsules in US market Lauras Labs launches pregabalin capsules in US market Nidhi Jani / Monday, July 22, 2019 0 1321 Article rating: 5.0 Pregabalin is used to treat nerve pain in people with diabetes (diabetic neuropathy), herpes zoster (post-herpetic neuralgia), or spinal cord injury. The said medicine is also used with other medications to treat partial onset seizures in adults and children who are at least 4 years old. Read more
Ten stocks close to their 52-weeks low Ten stocks close to their 52-weeks low Shital Jibhe / Monday, July 22, 2019 0 1012 Article rating: 5.0 Following stocks are close to their 52-weeks low as at 12:54 p.m. on July 22, 2019. Read more
Brookfield to invest in Reliance Tower Infra Trust Brookfield to invest in Reliance Tower Infra Trust Nidhi Jani / Monday, July 22, 2019 0 3345 Article rating: 5.0 Mukesh Ambani-led Reliance Industries’ subsidiary Reliance Industrial Investments has signed an agreement with BIF IV Jarvis India, an associate of Brookfield Asset Management Inc. for investment by Brookfield of Rs. 25,215 crore in the units proposed to be issued by the Tower Infrastructure Trust. Read more
Ten stocks close to their 52-weeks high Ten stocks close to their 52-weeks high Shital Jibhe / Monday, July 22, 2019 0 1839 Article rating: 5.0 The markets on July 22, 2019 opened gap down. BSE Sensex is trading at 37,943.91, down by 393.10 points and the Nifty is trading at 11,314.65, down by 104.60 points. Read more